Cristiana Iacuzzo1, Fabiola Giudici2,3, Serena Scomersi4, Rita Ceccherini4, Fabrizio Zanconati4, Daniele Generali5,6, Marina Bortul4. 1. Department of General Surgery, Academic Hospital of Trieste, Trieste University Hospital, Strada di Fiume 447, 34149, Trieste, Italy. cricsi@hotmail.it. 2. Department of Medicine, Surgery and Health Sciences, University of Trieste, Biostatistics Unit, Trieste, Italy. 3. Epidemiology and Public Health Department, University of Padua, Biostatistics Unit, Padua, Italy. 4. Breast Unit, Academic Hospital of Trieste, Trieste, Italy. 5. Breast Cancer Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy. 6. Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Abstract
PURPOSE: Prediction algorithms estimating survival rates for breast cancer (BC) based upon risk factors and treatment could give a help to the clinicians during multidisciplinary meetings. The aim of this study was to evaluate accuracy and clinical utility of three different scores: the Clinical Treatment Score Post-5 Years (CTS5), the PREDICT Score, and the Nottingham Prognostic Index (NPI). METHODS: This is a retrospective cohort analysis conducted on prospectively recorded databases of two EUSOMA certified centers (Breast Unit of Trieste Academic Hospital and of Cremona Hospital, Italy). We included patients with Luminal BC undergone to breast surgery between 2010 and 2015, and subsequent endocrine therapy for 5 years for curative intent. RESULTS: A total of 473 patients were enrolled in this study. ROC analysis showed fair accuracy for NPI, good accuracy for PREDICT, and optimal accuracy for CTS5 (AUC 0.7, 0.76, and 0.83, respectively). The three scores seemed strongly correlated in Spearman's rank correlation coefficient analysis. PREDICT partially overestimated OS in patients undergone to mastectomy, and in pT3-4, G3 tumors. Considering DRFS as a surrogate of OS, CTS5 showed women in intermediate and high risk class had shorter OS too (respectively p = 0.001 and p < 0.001). Combining scores does not improve prognostication power. CONCLUSION: Mathematical models may help clinicians in decision making (adjuvant therapies, CDK4/6i, genomic test's gray zones). CTS5 has the higher prognostic accuracy in predicting recurrence, while score predicting OS did not show substantial advances, proving that pN, G, and pT are still the most important variables in predicting OS.
PURPOSE: Prediction algorithms estimating survival rates for breast cancer (BC) based upon risk factors and treatment could give a help to the clinicians during multidisciplinary meetings. The aim of this study was to evaluate accuracy and clinical utility of three different scores: the Clinical Treatment Score Post-5 Years (CTS5), the PREDICT Score, and the Nottingham Prognostic Index (NPI). METHODS: This is a retrospective cohort analysis conducted on prospectively recorded databases of two EUSOMA certified centers (Breast Unit of Trieste Academic Hospital and of Cremona Hospital, Italy). We included patients with Luminal BC undergone to breast surgery between 2010 and 2015, and subsequent endocrine therapy for 5 years for curative intent. RESULTS: A total of 473 patients were enrolled in this study. ROC analysis showed fair accuracy for NPI, good accuracy for PREDICT, and optimal accuracy for CTS5 (AUC 0.7, 0.76, and 0.83, respectively). The three scores seemed strongly correlated in Spearman's rank correlation coefficient analysis. PREDICT partially overestimated OS in patients undergone to mastectomy, and in pT3-4, G3 tumors. Considering DRFS as a surrogate of OS, CTS5 showed women in intermediate and high risk class had shorter OS too (respectively p = 0.001 and p < 0.001). Combining scores does not improve prognostication power. CONCLUSION: Mathematical models may help clinicians in decision making (adjuvant therapies, CDK4/6i, genomic test's gray zones). CTS5 has the higher prognostic accuracy in predicting recurrence, while score predicting OS did not show substantial advances, proving that pN, G, and pT are still the most important variables in predicting OS.
Entities:
Keywords:
Breast cancer; Mathematical models; Overall survival; Recurrence; Scores
Authors: Mitch Dowsett; Ivana Sestak; Meredith M Regan; Andrew Dodson; Giuseppe Viale; Beat Thürlimann; Marco Colleoni; Jack Cuzick Journal: J Clin Oncol Date: 2018-04-20 Impact factor: 44.544
Authors: Carlo Boeri; Corrado Chiappa; Federica Galli; Valentina De Berardinis; Laura Bardelli; Giulio Carcano; Francesca Rovera Journal: Cancer Med Date: 2020-03-10 Impact factor: 4.452